Multilayered Organ-on-a-Chip for Topographic Neural Organoids

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for studying human brain diseases and developing therapies are limited by the ethical and practical challenges of accessing human brain samples, especially at early fetal and postnatal stages, and existing in vitro models fail to accurately replicate the complex topographic organization of the human brain.

Innovation Solution

A multilayered organ-on-a-chip system that generates three-dimensional molecular gradients to create topographically organized brain organoids, mimicking the developmental processes of the telencephalon, including specific brain regions and cell types, using pluripotent stem cells and microfluidic technology to establish precise morphogen gradients.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If human brain samples are used to study neurological disorders, then accurate disease mechanisms can be understood, but ethical and practical concerns arise including limited availability and inability to conduct well-controlled experiments

Engineering Contradiction:
Improveaccuracy of disease mechanism understandingVSAvoidavailability and experimental control
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent creates in vitro brain organoid models that copy and replicate the structural and functional characteristics of human brain tissue. These organoids are generated from pluripotent stem cells and differentiated to mimic human brain development, providing a copy of human brain tissue that can be used for research without ethical constraints while maintaining biological relevance for studying neurological disorders

Inventive Principle:
Principle #26Copying

Solution Approach 2:

The patent employs microfluidic systems to precisely control and establish concentration gradients of morphogens (such as BMP4, SHH, FGF8) in the organoid culture environment. By changing the parameters of morphogen concentrations and spatial distribution, the system directs brain region specification and cellular differentiation to recreate authentic human brain tissue architecture and function

Inventive Principle:
Principle #35Parameter changes

2Adaptability or versatility

If existing in vitro models are used, then ethical concerns are avoided, but they fail to accurately replicate the complex topographic organization of the human brain

Engineering Contradiction:
Improveethical feasibilityVSAvoidtopographic organization accuracy
Core Design Contradiction:
Adaptability or versatilityVSManufacturing precision

Solution Approach 1:

The patent implements spatially varying morphogen gradients where different concentrations and combinations of signaling molecules are delivered to specific regions of the organoid. This creates local differences in cellular differentiation and tissue organization, replicating the topographic variation found in human brain regions such as the cortex, hippocampus, and ganglionic eminences

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The patent transitions from two-dimensional cell cultures to three-dimensional organoid structures grown in microfluidic devices. This three-dimensional architecture enables complex spatial organization and topographic arrangement of different brain regions, accurately mimicking the hierarchical and spatial complexity of human brain tissue

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This system allows for the precise generation of topographic neural organoids with diverse cell types, enabling accurate modeling of neurological disorders and facilitating drug screening and therapeutic development by replicating human brain development and disease pathology.

Implementation Method 1

the first porous membrane allows for diffusion of a first fluid and an optional third fluid comprising cell factor(s), growth factor(s), cytokine(s) and/or differentiation factor(s) through the first porous membrane into the organoid chamber

Methodology Applied
Scientific EffectDiffusion: Diffusion

Data Source

PatentUS12054698B2Multilayered organ-on-a-chip systems and methods of use thereof
Publication Date: 2024.08.06 RGT UNIV OF CALIFORNIA
  • US12054698B2 patent drawing
  • US12054698B2 patent drawing
  • US12054698B2 patent drawing

AI summary

The disclosure provides for multilayered organ-on-a-chip systems that can be used to generate topographic neural organoids, and uses thereof, including as models to study neurological disorders.